ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 30, 2004

In Brief: Wittes DCT Acting Deputy Director; Spallone Leaves For Fox Chase; Ronald Evens Heads AUR

June 24, 1988

NCI CTEP-Approved Trials For the Month of August

August 29, 2014

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004

Solomon Gard Loses Final Cancer Battle

February 12, 1982